CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Grant or award Pres, Functional Regeneration acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 300,000 shares (grant or award)
- 4 Option exercise Director acquired 1,071,000 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.72 ($17,175)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $1.71 ($68,400)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $1.74 ($69,600)
- 4 Shares withheld for taxes Chief Business Officer gave up 3,734 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 1,262 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 3,734 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 14 of 29 · 563 filings